搜尋結果
2023
Chang, C-H. ,
Lin, B-J. ,
Chen, C-H. ,
Nguyen, N-L. ,
Hsieh, T-H. ,
Su, J-H. &
Chen, M-C. ,
2023 ,
於: Marine Drugs. 21 ,
2 研究成果: 雜誌貢獻 › 文章 › 同行評審
2021
Nguyen, N. L. ,
Vo, T. H. ,
Lin, Y. C. ,
Liaw, C. C. ,
Lu, M. K. ,
Cheng, J. J. ,
Chen, M. C. &
Kuo, Y. H. ,
2月 26 2021 ,
於: Journal of Natural Products. 84 ,
2 ,
p. 259-267 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
oleanane
100%
Antiangiogenic
77%
Saponins
66%
Saponin
64%
Oleanolic Acid
55%
Mehndiratta, S. ,
Chen, M. C. ,
Chao, Y. H. ,
Lee, C. H. ,
Liou, J. P. ,
Lai, M. J. &
Lee, H. Y. ,
1月 1 2021 ,
於: Journal of Enzyme Inhibition and Medicinal Chemistry. 36 ,
1 ,
p. 74-84 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylases
100%
Apoptotic
98%
A549 Cells
94%
Histone
91%
Antiproliferative
85%
Ojha, R. ,
Chen, I. C. ,
Hsieh, C. M. ,
Nepali, K. ,
Lai, R. W. ,
Hsu, K. C. ,
Lin, T. E. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
2021 , (接受/付印)
於: Journal of Medicinal Chemistry. 64 ,
24 ,
p. 17824-17845 22 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pargyline
100%
Hydroxamic Acid
76%
Histone Deacetylase Inhibitors
73%
Antiproliferative
62%
Bioavailability
61%
2020
Nguyen, N. L. ,
Vo, T. H. ,
Lin, Y. C. ,
Liaw, C. C. ,
Lin, Z. H. ,
Chen, M. C. &
Kuo, Y. H. ,
1月 28 2020 ,
於: Molecules. 25 ,
3 , 551.
研究成果: 雜誌貢獻 › 文章 › 同行評審
bioassay
100%
metabolites
91%
Biological Assay
71%
Antiproliferative
69%
isolation
65%
Lin, Y. C. ,
Chen, M. C. ,
Hsieh, T. H. ,
Liou, J. P. &
Chen, C. H. ,
4月 15 2020 ,
於: Aging. 12 ,
7 ,
p. 5764-5780 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Urinary Bladder Neoplasms
100%
PF-670462
22%
erdafitinib
21%
Pyrrolo(2,3-d)pyrimidine
20%
Therapeutics
17%
Wu, W. C. ,
Liu, Y. M. ,
Liao, Y. H. ,
Hsu, K. C. ,
Lien, S. T. ,
Chen, I. C. ,
Lai, M. J. ,
Li, Y. H. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
10月 1 2020 ,
於: European Journal of Medicinal Chemistry. 203 , 112540.
研究成果: 雜誌貢獻 › 文章 › 同行評審
HSP90 Heat-Shock Proteins
100%
Antineoplastic Agents
72%
Non-Small Cell Lung Carcinoma
67%
Antineoplastic Agent
67%
Colorectal Neoplasms
60%
Ojha, R. ,
Nepali, K. ,
Chen, C. H. ,
Chuang, K. H. ,
Wu, T. Y. ,
Lin, T. E. ,
Hsu, K. C. ,
Chao, M. W. ,
Lai, M. J. ,
Lin, M. H. ,
Huang, H. L. ,
Chang, C. D. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
3月 15 2020 ,
於: European Journal of Medicinal Chemistry. 190 , 112086.
研究成果: 雜誌貢獻 › 文章 › 同行評審
50 Percent Growth Inhibition
100%
compound 17
97%
Lung Neoplasms
58%
Inhibitory Concentration 50
53%
Lung
39%
Mehndiratta, S. ,
Lin, M. H. ,
Wu, Y. W. ,
Chen, C. H. ,
Wu, T. Y. ,
Chuang, K. H. ,
Chao, M. W. ,
Chen, Y. Y. ,
Pan, S. L. ,
Chen, M. C. &
Liou, J. P. ,
1月 1 2020 ,
於: European Journal of Medicinal Chemistry. 185 ,
p. 111725 111725.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Anilides
100%
HSP90 Heat-Shock Proteins
73%
Anilide
72%
Histone Deacetylase Inhibitors
65%
Histone
59%
Wang, S. W. ,
Lin, M. H. ,
Hsu, F. C. ,
Chen, M. C. ,
Liou, J. P. ,
Liu, Y. T. ,
Chen, S. S. &
Lee, H. Y. ,
2月 1 2020 ,
於: Bioorganic and Medicinal Chemistry. 28 ,
3 ,
p. 115250 115250.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antiproliferative
100%
Protein Isoforms
80%
HCT116 Cells
64%
Ether
55%
A549 Cells
55%
2019
Lai, M. J. ,
Ojha, R. ,
Lin, M. H. ,
Liu, Y. M. ,
Lee, H. Y. ,
Lin, T. E. ,
Hsu, K. C. ,
Chang, C. Y. ,
Chen, M. C. ,
Nepali, K. ,
Chang, J. Y. &
Liou, J. P. ,
1月 15 2019 ,
於: European Journal of Medicinal Chemistry. 162 ,
p. 612-630 19 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
indoline
100%
Benzamides
91%
Histone Deacetylases
63%
Tubulin
58%
Histone
58%
Nepali, K. ,
Lin, M. H. ,
Chao, M. W. ,
Peng, S. J. ,
Hsu, K. C. ,
Eight Lin, T. ,
Chen, M. C. ,
Lai, M. J. ,
Pan, S. L. &
Liou, J. P. ,
10月 1 2019 ,
於: Bioorganic Chemistry. 91 , 103119.
研究成果: 雜誌貢獻 › 文章 › 同行評審
resorcinol
100%
quinoline
91%
Growth Inhibitors
83%
PC-3 Cells
78%
Amides
75%
Tsai, M. H. ,
Liu, J. F. ,
Chiang, Y. C. ,
Hu, S. C. S. ,
Hsu, L. F. ,
Lin, Y. C. ,
Lin, Z. C. ,
Lee, H. C. ,
Chen, M. C. ,
Huang, C. L. &
Lee, C. W. ,
5月 21 2019 ,
於: Oncotarget. 10 ,
36 ,
p. 3430 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
artocarpin flavonoid
100%
Non-Small Cell Lung Carcinoma
39%
Apoptosis
27%
Chen, M. C. ,
Wang, G. J. ,
Kuo, Y. H. ,
Chiang, Y. R. ,
Cho, T. Y. ,
Ju, Y. M. &
Lee, T. H. ,
1月 1 2019 ,
於: Journal of Food and Drug Analysis. 27 ,
1 ,
p. 111-117 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Isoptera
100%
Ethers
91%
Xylaria
87%
termite mounds
82%
medicinal fungi
79%
Chen, M. C. ,
Lin, Y. C. ,
Liao, Y. H. ,
Liou, J. P. &
Chen, C. H. ,
10月 2019 ,
於: Cancers. 11 ,
10 , 1617.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Colorectal Neoplasms
100%
Ligands
88%
Apoptosis
76%
Autophagy
72%
Cell Death
57%
2017
Tsai, M. H. ,
Liu, J. F. ,
Chiang, Y. C. ,
Hu, S. C. S. ,
Hsu, L. F. ,
Lin, Y. C. ,
Lin, Z. C. ,
Lee, H. C. ,
Chen, M. C. ,
Huang, C. L. &
Lee, C. W. ,
2017 ,
於: Oncotarget. 8 ,
17 ,
p. 28342-28358 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
artocarpin flavonoid
100%
artocarpin lectin
89%
Non-Small Cell Lung Carcinoma
39%
Reactive Oxygen Species
35%
Apoptosis
27%
Wu, T. Y. ,
Cho, T. Y. ,
Lu, C. K. ,
Liou, J. P. &
Chen, M. C. ,
12月 1 2017 ,
於: Scientific Reports. 7 ,
1 , 12406.
研究成果: 雜誌貢獻 › 文章 › 同行評審
indoline
100%
benzenesulfonamide
95%
Autophagy
52%
Colorectal Neoplasms
43%
Cell Death
41%
Chen, M. C. ,
Cho, T. Y. ,
Kuo, Y. H. &
Lee, T. H. ,
9月 22 2017 ,
於: Journal of Natural Products. 80 ,
9 ,
p. 2439-2446 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
antroquinonol
100%
Antroquinonol
97%
Antrodia
81%
Meroterpenoid
72%
Fungi
43%
Nepali, K. ,
Lee, H-Y. ,
Lai, M-J. ,
Ojha, R. ,
Wu, T. Y. ,
Wu, G. X. ,
Chen, M-C. &
Liou, J-P. ,
2月 15 2017 ,
於: European Journal of Medicinal Chemistry. 127 ,
p. 115-127 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tubastatin A
100%
Carbolines
78%
tubastatin A
60%
Hydroxamic Acid
58%
Histone Deacetylases
55%
Chen, M. C. ,
Kuo, Y. C. ,
Hsu, C. M. ,
Chen, Y. L. ,
Shen, C. C. ,
Teng, C. M. &
Pan, S. L. ,
4月 7 2017 ,
於: Scientific Reports. 7 , 46149.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Inducer
100%
Apoptotic
98%
Membrane Potential
93%
Marker
75%
Cell Viability
42%
2016
Cho, T. Y. ,
Wang, G. J. ,
Ju, Y. M. ,
Chen, M. C. &
Lee, T. H. ,
5月 1 2016 ,
於: Journal of the Chinese Chemical Society. 63 ,
5 ,
p. 404-409 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Benzofuran
100%
Rotating Frame Overhauser Enhancement Spectroscopy
53%
Cyclo(L-Leu-L-Pro)
42%
Absolute Configuration
38%
Ethyl Acetate
38%
Huang, H. L. ,
Chao, M. W. ,
Chen, C. C. ,
Cheng, C. C. ,
Chen, M. C. ,
Lin, C. F. ,
Liou, J. P. ,
Teng, C. M. &
Pan, S. L. ,
6月 9 2016 ,
於: Scientific Reports. 6 , 27794.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antimitotic Agents
100%
Pancreatic Carcinoma
84%
Pancreatic Neoplasms
66%
In Vitro Techniques
30%
Polyploidy
29%
Huang, H. L. ,
Chao, M. W. ,
Li, Y. C. ,
Chang, L. H. ,
Chen, C-H. ,
Chen, M. C. ,
Cheng, C. C. ,
Liou, J. P. ,
Teng, C. M. &
Pan, S. L. ,
8月 16 2016 ,
於: Scientific Reports. 6 , 31664.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Antineoplastic Agents
100%
Ovarian Neoplasms
94%
Cisplatin
93%
Apoptosis
63%
Pharmaceutical Preparations
43%
Chen, M-C. ,
Huang, H-H. ,
Lai, C-Y. ,
Lin, Y-J. ,
Liou, J-P. ,
Lai, M-J. ,
Li, Y-H. ,
Teng, C-M. &
Yang, C-R. ,
1月 5 2016 ,
於: Oncotarget. 7 ,
1 ,
p. 402-17 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Histone Deacetylase Inhibitors
48%
Hepatocellular Carcinoma
33%
Tumor Necrosis Factor-alpha
29%
Ligands
29%
2015
Lin, R. D. ,
Chen, M. C. ,
Liu, Y. L. ,
Lin, Y. T. ,
Lu, M. K. ,
Hsu, F-L. &
Lee, M. H. ,
12月 2 2015 ,
於: International Journal of Molecular Sciences. 16 ,
12 ,
p. 28598-28613 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pyracantha
100%
Taiwan
64%
Cosmetics
61%
Monophenol Monooxygenase
57%
Cosmetic
46%
Lai, M-J. ,
Lee, H. Y. ,
Chuang, H-Y. ,
Chang, L-H. ,
Tsai, A-C. ,
Chen, M. C. ,
Huang, H-L. ,
Wu, Y-W. ,
Teng, C-M. ,
Pan, S. L. ,
Liu, Y-M. ,
Mehndiratta, S. &
Liou, J. P. ,
8月 27 2015 ,
於: Journal of Medicinal Chemistry. 58 ,
16 ,
p. 6549-6558 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
benzenesulfonamide
100%
STAT3 Transcription Factor
69%
Tubulin
61%
Phosphorylation
39%
50 Percent Growth Inhibition
38%
Liu, Y-M. ,
Lee, H. Y. ,
Lai, M-J. ,
Pan, S. L. ,
Huang, H-L. ,
Kuo, F-C. ,
Chen, M. C. &
Liou, J. P. ,
8月 17 2015 ,
於: Organic and Biomolecular Chemistry. 13 ,
40 ,
p. 10226-10235 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
Apoptosis Induction
90%
HCT116 Cells
79%
Histone Deacetylase Inhibitors
72%
inhibitors
71%
Chen, M. C. ,
Chang, C. J. ,
Lu, Y. H. ,
Niu, D. M. ,
Lou, H. Y. &
Chang, C. C. ,
3月 13 2015 ,
於: Journal of Clinical Gastroenterology. 49 ,
3 ,
p. 256-257 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, M. C. ,
Zhou, B. ,
Zhang, K. ,
Yuan, Y. C. ,
Un, F. ,
Hu, S. ,
Chou, C. M. ,
Chen, C. H. ,
Wu, J. ,
Wang, Y. ,
Liu, X. ,
Smith, D. L. ,
Li, H. ,
Liu, Z. ,
Warden, C. D. ,
Su, L. ,
Malkas, L. H. ,
Chung, Y. M. ,
Hu, M. C. T. &
Yen, Y. ,
6月 1 2015 ,
於: Molecular Pharmacology. 87 ,
6 ,
p. 996-1005 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
DNA Repair
66%
DNA Damage
31%
N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide
30%
Deoxyribonucleotides
18%
Antimetabolites
16%
2014
Lee, H. Y. ,
Tsai, A. C. ,
Chen, M. C. ,
Shen, P. J. ,
Cheng, Y. C. ,
Kuo, C. C. ,
Pan, S. L. ,
Liu, Y. M. ,
Liu, J. F. ,
Yeh, T. K. ,
Wang, J. C. ,
Chang, C. Y. ,
Chang, J. Y. &
Liou, J. P. ,
5月 22 2014 ,
於: Journal of Medicinal Chemistry. 57 ,
10 ,
p. 4009-4022 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histone Deacetylase 6
100%
HCT116 Cells
79%
Histone
66%
7-azaindole dimer
64%
Antiproliferative
61%
Mehndiratta, S. ,
Chiang, Y-F. ,
Lai, M-J. ,
Lee, H. Y. ,
Chen, M. C. ,
Kuo, C-C. ,
Chang, C-Y. ,
Chang, J-Y. &
Liou, J. P. ,
9月 1 2014 ,
於: Bioorganic and Medicinal Chemistry. 22 ,
17 ,
p. 4917-4923 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
indoline
100%
Vascular Targeting Agent
96%
benzenesulfonamide
95%
Antimitotic
80%
Antimitotic Agents
78%
Wu, S. Y. ,
Pan, S. L. ,
Xiao, Z. Y. ,
Hsu, J. L. ,
Chen, M. C. ,
Lee, K. H. &
Teng, C. M. ,
11月 5 2014 ,
於: PLoS ONE. 9 ,
11 , e112220.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Type II DNA Topoisomerase
100%
Renal Cell Carcinoma
74%
4'-demethylepipodophyllotoxin
73%
DNA Damage
67%
Reactive Oxygen Species
61%
Chen, C. H. ,
Chen, M. C. ,
Wang, J. C. ,
Tsai, A. C. ,
Chen, C. S. ,
Liou, J. P. ,
Pan, S. L. &
Teng, C. M. ,
2014 ,
於: Clinical Cancer Research. 20 ,
5 ,
p. 1274-1287 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Sorafenib
52%
Histone Deacetylase Inhibitors
49%
Liver Neoplasms
42%
In Vitro Techniques
18%
2013
Chen, M. C. ,
Chen, C. H. ,
Wang, J. C. ,
Tsai, A. C. ,
Liou, J. P. ,
Pan, S. L. &
Teng, C. M. ,
9月 2013 ,
於: Cell Death and Disease. 4 ,
9 , e810.
研究成果: 雜誌貢獻 › 文章 › 同行評審
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
100%
Erlotinib Hydrochloride
54%
Histone Deacetylase Inhibitors
49%
ErbB Receptors
40%
Cell Death
32%
Chen, M. C. ,
Chen, C. H. ,
Liu, Y. N. ,
Wang, H. P. ,
Pan, S. L. &
Teng, C. M. ,
8月 19 2013 ,
於: Cancer Letters. 336 ,
2 ,
p. 370-378 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acid
100%
3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
76%
A549 Cells
42%
Autophagy
37%
Non-Small Cell Lung Carcinoma
34%
2012
Lai, C. Y. ,
Tsai, A. C. ,
Chen, M. C. ,
Chang, L. H. ,
Sun, H. L. ,
Chang, Y. L. ,
Chen, C. C. ,
Teng, C. M. &
Pan, S. L. ,
8月 13 2012 ,
於: PLoS One. 7 ,
8 , e42192.
研究成果: 雜誌貢獻 › 文章 › 同行評審
aciculatin
100%
Cell Death
44%
DNA damage
41%
apoptosis
38%
neoplasm cells
38%
Chen, M. C. ,
Pan, S. L. ,
Shi, Q. ,
Xiao, Z. ,
Lee, K. H. ,
Li, T. K. &
Teng, C. M. ,
1月 2012 ,
於: Cancer Science. 103 ,
1 ,
p. 80-87 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
4-((4'-benzylpiperdin-4-yl)amino)-4'-O-demethylepipodophyllotoxin
100%
Type II DNA Topoisomerase
50%
A549 Cells
42%
Non-Small Cell Lung Carcinoma
34%
Apoptosis
23%
2011
Chen, C-H. ,
Huang, P. H. ,
Chu, P. C. ,
Chen, M. C. ,
Chou, C. C. ,
Wang, D. ,
Kulp, S. K. ,
Teng, C. M. ,
Wang, Q. &
Chen, C. S. ,
3月 25 2011 ,
於: Journal of Biological Chemistry. 286 ,
12 ,
p. 9968-9976 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Kruppel-Like Factor 6
100%
Tumor Suppressor Genes
54%
Histones
52%
Epigenomics
48%
Prostatic Neoplasms
44%
Chen, M. C. ,
Chen, C-H. ,
Chuang, H. C. ,
Kulp, S. K. ,
Teng, C. M. &
Chen, C. S. ,
1月 2011 ,
於: Hepatology. 53 ,
1 ,
p. 148-159 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Type II DNA Topoisomerase
100%
Histone Deacetylase Inhibitors
90%
Hepatocellular Carcinoma
62%
Phosphorylation
53%
COP9 Signalosome Complex
25%